- Taking breast cancer prevention drug beyond 5 years may not raise survivalwbrc.com
- A New Antibody For Treating Acute Lymphocytic Leukemia?Forbes
- Novartis CEO plays down prospects for Actelion bid: BlickReuters
- 5 Ways to Improve Your Relationship Skills at WorkInc.
- Backers inject €10m into OpsonaThe Times
- Biotech group Actelion, Johnson & Johnson confirm deal talksReuters
- Promise of genetic sequencing frustrated by the cost of medicines for rare cancer patientsSydney Morning Herald
- Money in Medicine: Brian Druker on why he gets money from Gilead, not from Gleevecbizjournals.com
- Novartis acquires Selexysjournalrecord.com
- The 5 Biggest Holiday Stressors (and How to Get Over Them)Inc.
- MNovartis buys U.S.-based sickle cell drugmaker Selexysmarketwatch.com
- GlaxoSmithKline seeks U.S. approval for triple lung drugmetro.us
- FNovartis buys Selexys Pharmaceuticals for up to $665mft.com
- Alphabet's autofocusing contact lens won't be tested in 2016engadget
- The Motley Fool: Useful tips on investingseattletimes.com
- Google's smart contact lenses in crisis as partner Novartis abandons plans to trial tech in 2016Daily Mail
- Novartis backs off from 2016 date for testing Google autofocus lensReuters
- Seventh Sense gets $10 million funding injectionbizjournals.com
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.